MX2021011183A - Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria. - Google Patents

Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria.

Info

Publication number
MX2021011183A
MX2021011183A MX2021011183A MX2021011183A MX2021011183A MX 2021011183 A MX2021011183 A MX 2021011183A MX 2021011183 A MX2021011183 A MX 2021011183A MX 2021011183 A MX2021011183 A MX 2021011183A MX 2021011183 A MX2021011183 A MX 2021011183A
Authority
MX
Mexico
Prior art keywords
phytoecdysones
derivatives
treatment
lung function
impaired lung
Prior art date
Application number
MX2021011183A
Other languages
English (en)
Inventor
René LAFONT
Stanislas Veillet
Mathilde Latil
Pierre Dilda
Original Assignee
Biophytis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis filed Critical Biophytis
Publication of MX2021011183A publication Critical patent/MX2021011183A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se refiere a las fitoecdisonas y lo derivados de éstas para su uso en el tratamiento de la alteración de la función respiratoria en un mamífero, en particular en el contexto de una patología neuromuscular y más en particular cuando la alteración de la función respiratoria es con relación a una alteración de las propiedades mecánicas del tejido pulmonar.
MX2021011183A 2019-03-15 2020-03-12 Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria. MX2021011183A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1902727A FR3093641B1 (fr) 2019-03-15 2019-03-15 Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de l’altération de la fonction respiratoire
PCT/EP2020/056591 WO2020187679A1 (fr) 2019-03-15 2020-03-12 Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de l'altération de la fonction respiratoire

Publications (1)

Publication Number Publication Date
MX2021011183A true MX2021011183A (es) 2022-01-18

Family

ID=67660224

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011183A MX2021011183A (es) 2019-03-15 2020-03-12 Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria.

Country Status (14)

Country Link
US (1) US20220152060A1 (es)
EP (1) EP3937949B1 (es)
JP (1) JP2022525410A (es)
KR (1) KR20210141578A (es)
CN (1) CN113727717A (es)
BR (1) BR112021018198A2 (es)
CA (1) CA3133230A1 (es)
DK (1) DK3937949T3 (es)
ES (1) ES2967044T3 (es)
FR (1) FR3093641B1 (es)
MX (1) MX2021011183A (es)
PL (1) PL3937949T3 (es)
PT (1) PT3937949T (es)
WO (1) WO2020187679A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3108504B1 (fr) * 2020-03-30 2023-03-31 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement d’altérations de la fonction respiratoire lors d’une infection virale
FR3143975A1 (fr) * 2022-12-23 2024-06-28 Biophytis Phytoecdysones pour leur utilisation dans le traitement de pathologies respiratoires inflammatoires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2257906C2 (ru) * 2003-07-08 2005-08-10 Дармограй Василий Николаевич Способ лечения острых неспецифических нагноительных заболеваний легких и плевры
TWI421082B (zh) * 2011-09-09 2014-01-01 Chung Hwa University Of Medical Technolgy 蛻皮激素用以製備治療腎纖維化藥物之用途及醫藥組合物用以製備治療腎纖維化之藥物的用途
FR3021318B1 (fr) * 2014-05-20 2017-04-28 Inst Biophytis Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments
AU2015317862A1 (en) * 2014-09-17 2017-04-06 Intrexon Corporation Boron-containing diacylhydrazine compounds
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation

Also Published As

Publication number Publication date
EP3937949A1 (fr) 2022-01-19
BR112021018198A2 (pt) 2021-11-16
PT3937949T (pt) 2024-01-02
EP3937949B1 (fr) 2023-09-27
PL3937949T3 (pl) 2024-04-22
FR3093641B1 (fr) 2023-11-03
JP2022525410A (ja) 2022-05-13
CA3133230A1 (fr) 2020-09-24
US20220152060A1 (en) 2022-05-19
DK3937949T3 (da) 2023-12-18
KR20210141578A (ko) 2021-11-23
WO2020187679A1 (fr) 2020-09-24
FR3093641A1 (fr) 2020-09-18
ES2967044T3 (es) 2024-04-25
CN113727717A (zh) 2021-11-30

Similar Documents

Publication Publication Date Title
MX2023014569A (es) Anticuerpos anti-sirpa.
EA201370208A1 (ru) Формы рифаксимина и их применение
MY180626A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MX2010004074A (es) Combinacion 059.
MY145439A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
CL2007002382A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
MX2021011183A (es) Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria.
MX2018008644A (es) Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2021002322A (es) Nuevos metodos.
EA201400423A1 (ru) Фармацевтические препараты и их применение при лечении половой дисфункции у женщин
MX2020012800A (es) Cannabinoides y usos de los mismos.
PH12020551994A1 (en) Tlr7 agonists
CO2022005113A2 (es) Métodos de tratamiento para modificar la hemodinámica
MX2021011269A (es) Tratamiento de enfermedades y trastornos asociados a las mitocondrias, incluyendo los sintomas de los mismos usando pridopidina.
MX2023014530A (es) Nitroxolina para su uso en el tratamiento de neurofibroma cutaneo.
MX2021008249A (es) Fragmentos de defensina para su uso en tratamientos o profilaxis.
JOP20210008A1 (ar) أنواع أبيراز مذابة، وطرق لاستخدامها
EA202190151A1 (ru) Фармацевтическая комбинация для применения при возрастных и/или дегенеративных заболеваниях
MX2022012632A (es) Uso de inhibidores del bromodominio para el tratamiento de la enfermedad de huntington.
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
PH12020551331A1 (en) Treatment and prevention of pre-eclampsia
WO2020221892A3 (en) Rebamipide for use in prevention and/or treatment of synucleinopathies
MX2021011151A (es) Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de enfermedades neuromusculares.
GEP20207136B (en) Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition